O. T. Grati

Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening.

Y. Allory, S. Vacher, I. Bièche, 2022, European journal of cancer.